- Novartis and Orionis strike second molecular glue deal for $40M upfrontNovartis is doubling down on its partnership with Orionis Biosciences in a deal worth $40 million upfront and up to $1.4 billion spread across milestones. The Boston and Belgian biotech will ...Endpoints · 1mo ago↗ source
- SonoThera raises $125M for non-viral gene therapy approachSonoThera has secured $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in Duchenne muscular dystrophy and autosomal d…Endpoints · 1mo ago↗ source
- Shattuck raises $75M; Servier inks neuro ASO pact with n-Lorem FoundationShattuck Labs initiates $75M public offering: The US biotech {$STTK} is selling over 10.5 million shares for $4 apiece, and issuing pre-funded warrants for certain investors. The offering is set to…